Bayer Pharmaceuticals Corporation Informs Health Care Professionals Of Important Safety Revisions To The Trasylol Label

... Bayer Pharmaceuticals Corporation, in collaboration with the FDA, is informing health care professionals of important safety revisions to the U.S. product information for Trasylol(R) (aprotinin injection) following an FDA Advisory Committee meeting earlier this year. These safety revisions relate primarily to renal function and hypersensitivity. [click link for full article] ...